SCHEMBL14246713

SCHEMBL14246713

CC(C(N)=O)S(=O)(=O)CC1CC1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SMYD3 Q9H7B4 1/20 0.37
EPHX1 P07099 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
ALOX5 P09917 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isobutyramide SCHEMBL8899979 0.74 EPHX2 (0.39) EPHX1TDP1ALOX5
SCHEMBL4766616 0.73 SMYD3 (0.43) SMYD3EPHX1
SCHEMBL12274452 0.73 ACACB (0.33)
SCHEMBL4013193 0.68 SMYD3 (0.36) SMYD3EPHX1
SCHEMBL1161216 0.68 EPHX1 (0.37) SMYD3EPHX1ALOX5
SCHEMBL3351207 0.67 CA1 (0.33)
SCHEMBL25720844 0.67 ACACB (0.31)
SCHEMBL12540125 0.66
SCHEMBL17069436 0.66
SCHEMBL18624724 0.66 ADH1B (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2720692-A2 CATHEPSIN INHIBITORS FOR TREATING MICROGLIA-MEDIATED NEURON LOSS IN THE CENTRAL NERVOUS SYSTEM Virobay, Inc. (US) 2014-04-23 EP disclosed
WO-2012174552-A2 CATHEPSIN INHIBITORS FOR TREATING MICROGLIA-MEDIATED NEURON LOSS IN THE CENTRAL NERVOUS SYSTEM VIROBAY, INC. (US) 2012-12-20 WO disclosed